Actinium Pharmaceuticals Inc (ATNM)
9.95
+0.06
(+0.61%)
USD |
NYAM |
May 15, 15:21
Actinium Pharmaceuticals Price: 9.95 for May 15, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 14, 2024 | 9.06 | 10.24 | 9.06 | 9.89 | 951882.0 |
| May 13, 2024 | 8.98 | 9.07 | 8.800 | 8.86 | 275834.0 |
| May 10, 2024 | 8.91 | 9.00 | 8.40 | 8.73 | 196229.0 |
| May 09, 2024 | 8.68 | 8.970 | 8.54 | 8.90 | 224438.0 |
| May 08, 2024 | 8.75 | 8.75 | 8.36 | 8.71 | 157700.0 |
| May 07, 2024 | 8.88 | 8.94 | 8.45 | 8.81 | 227055.0 |
| May 06, 2024 | 9.00 | 9.00 | 8.35 | 8.84 | 288175.0 |
| May 03, 2024 | 8.95 | 9.20 | 8.54 | 8.96 | 528663.0 |
| May 02, 2024 | 7.95 | 8.81 | 7.91 | 8.75 | 682893.0 |
| May 01, 2024 | 7.68 | 7.96 | 7.605 | 7.78 | 227262.0 |
| Apr 30, 2024 | 7.31 | 7.979 | 7.31 | 7.70 | 282660.0 |
| Apr 29, 2024 | 6.90 | 7.48 | 6.88 | 7.38 | 244844.0 |
| Apr 26, 2024 | 6.58 | 6.92 | 6.485 | 6.87 | 206378.0 |
| Apr 25, 2024 | 6.96 | 6.97 | 6.47 | 6.56 | 328850.0 |
| Apr 24, 2024 | 6.93 | 7.32 | 6.881 | 7.06 | 153433.0 |
| Apr 23, 2024 | 7.03 | 7.43 | 6.85 | 6.96 | 185256.0 |
| Apr 22, 2024 | 6.92 | 7.34 | 6.82 | 7.17 | 192609.0 |
| Apr 19, 2024 | 6.64 | 7.01 | 6.60 | 6.85 | 347635.0 |
| Apr 18, 2024 | 7.26 | 7.512 | 6.66 | 6.67 | 420871.0 |
| Apr 17, 2024 | 7.73 | 7.817 | 7.20 | 7.25 | 297442.0 |
| Apr 16, 2024 | 8.45 | 8.45 | 7.65 | 7.74 | 373923.0 |
| Apr 15, 2024 | 8.95 | 9.10 | 8.28 | 8.44 | 255522.0 |
| Apr 12, 2024 | 8.97 | 9.04 | 8.55 | 9.00 | 303644.0 |
| Apr 11, 2024 | 9.02 | 9.28 | 9.00 | 9.09 | 461385.0 |
| Apr 10, 2024 | 8.79 | 9.15 | 8.72 | 8.99 | 344890.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.02
Minimum
Nov 28 2023
18.00
Maximum
Aug 03 2020
7.709
Average
7.388
Median
Price Benchmarks
| Perspective Therapeutics Inc | 1.565 |
| Eli Lilly and Co | 781.03 |
| Cellectar Biosciences Inc | 3.35 |
| Outlook Therapeutics Inc | 7.54 |
| Bristol-Myers Squibb Co | 44.52 |
Price Related Metrics
| PEG Ratio | -0.1620 |
| Price to Book Value | 6.757 |
| Earnings Yield | -17.19% |
| Market Cap | 296.35M |
| PEGY Ratio | -0.1620 |